Article from Natural Product Insider
In the study, ten women who tested HPV-positive with the Cervista HPV HR Test were treated orally with AHCC once daily for up to six months. Five achieved a negative HPV test result – three with confirmed eradication after stopping AHCC – and the remaining two responders continued on with the study.
Further investigation in a formal phase II randomized placebo controlled study is now being enrolled at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
“With this study, for the first time, we’ve shown it’s possible to eradicate HPV in women using AHCC for only three months or up to six months,”Smith said. The research has a specific focus on the safe and effective use of nutritional and herbal supplements with pharmacologic modalities as it relates to women’s health and cancer.
AHCC works as an immunotherapy that uses a body’s own immune system to help fight disease. Human and in-vivo studies have shown that AHCC increases the number and/or activity of natural killer (NK) cells, dendritic cells and cytokines, which enable the body to effectively respond to infections and block the proliferation of tumors.
Smith’s research findings were chosen for presentation in the “Best of SIO” session on October 28, 2014, from a record number of abstracts submitted for the 11th International Conference in Houston, Texas. The Society for Integrative Oncology is the leading worldwide organization dedicated to integrative medicine specific to cancer patients.